Welcome!

News Feed Item

Global Neurotechnology Industry 2014 Report: Company Profiles and Pipeline Analysis from Over 500 Companies and 20 Illnesses

DUBLIN, IRELAND -- (Marketwired) -- 08/15/14 -- Research and Markets (http://www.researchandmarkets.com/research/s7qvsb/the) has announced the addition of a new report "Neurotech Industry 2014 Report" to their offering.

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 20 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Report Highlights:

--  More than 500 profiles of public and private neurotech companies
    including drugs, devices and diagnostics
--  Pipelines and market analysis for 20 brain and nervous system illnesses
    including: addiction, Alzheimer's disease, anxiety, attention disorders,
    depression, epilepsy, hearing loss, insomnia, mild cognitive impairment,
    migraine, multiple sclerosis, obesity, pain, Parkinson's disease,
    retinal disorders, schizophrenia, stroke, and traumatic brain injury
--  Top neurotech investors, venture capital firms, and venture capital
    trends (1999-Q12014)
--  Neurotech IPOs (2004-Q12014), M&A (2004-Q12014), Partnering and
    Licensing deals (2005-Q12014) and public neurotech stock performance
--  Analysis of biological basis, current treatment options, and emerging
    therapeutic strategies
--  Analysis of compounds, cell therapies and devices in clinical trials
    (and abandoned) by company, mechanism of action and stage of development
    for each indication
--  Global and US market size, worldwide revenues for each indication
--  Extensive discussion of specific technological, demographic, regulatory
    and intellectual property trends

Key Topics Covered:

1: Executive Summary

--  The Brain Industry Revealed
--  Investment Risks and Opportunities

Key Industry Facts and Findings

2: Trends and Drivers

--  Converging Technology Drivers
--  Demographic Drivers
--  Social Drivers
--  Economic Drivers
--  Research Funding
--  Intellectual Property Trends

Neurotech Merger and Acquisition Activity (2005-Q1,2014)

3: Neuropharmaceutical Sector

--  Neuropharmaceutical Sector Overview
--  Neuropharmaceutical Partnering and Licensing
--  Neurology Markets and Pipelines
--  Psychiatry Markets and Pipelines
--  Sensory Markets and Pipelines

4: Stem Cells and Neuroregeneration

--  Defining Stem Cell Markets and Players
--  Stem Cell Approaches
--  Markets and Treatments in Development

5: Neurodevice Sector

--  Neurodevice Sector Overview
--  Neuroprosthetic Devices
--  Neuromodulation Devices
--  Neurosurgical devices
--  Neurosoftware
--  Therapeutic NeuroGaming

6: Neurodiagnostics Sector

--  Neurodiagnostic Sector Overview
--  Neuroimaging Technologies
--  In Vitro Diagnostics
--  Neuroinformatics

7: Private Neurotechnology Investment

--  Venture Capital Investment Trends
--  Neurotech Venture Capital Investment

8: Public Neurotechnology Investment

--  Investing in Public Neurotech Companies
--  Neurotech Initial Public Offerings
--  NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

--  Leading Neurotechnology Research Centers
--  Places to Watch

10: Leading Neurotechnology Regions

--  The Global Neurotech Economy
--  Nexus Ranking and Methodology
--  Established Neurotech Nexus
--  Emerging Neurotech Nexus
--  Nascent Neurotech Nexus
--  Conclusions and Policy Recommendations

11: Company Profiles

--  Neuropharmaceutical & Cell Therapy Companies: Private
--  Neuropharmaceutical & Cell Therapy Companies: Public
--  Neurodevice Companies: Private
--  Neurodevice Companies: Public
--  Neurodiagnostic Companies: Private
--  Neurodiagnostic Companies: Public

12: Index

For more information visit http://www.researchandmarkets.com/research/s7qvsb/the

Source: NeuroInsights

Sector: Pharmaceuticals

Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Pharmaceuticals include:

--  Pfizer, Inc.
--  Novartis International AG.
--  GlaxoSmithKline plc
--  Merck & Co., Inc.
--  Genentech Inc.
--  McKinsey & Company, Inc.
--  Novo Nordisk
--  IGEN Biotech Group AG
--  Sanofi S.A.
--  Allergan, Inc.
--  FORUM Pharmaceuticals Inc
--  Bio-Rad Laboratories
--  Bain & Company
--  Nestle Health Science
--  Pacira Pharmaceuticals, Inc
--  DBV Technologies SA
--  Chimerix, Inc.

Contacts:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
DX World EXPO, LLC, a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Conference Guru has been named “Media Sponsor” of the 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organizers to pass great deals to gre...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develop...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...